{
  "id": 2033418,
  "title": "Moderna's skin cancer vaccine shows promise in trial",
  "url": "https://urgent.news/2026/08/19/modernas-skin-cancer-vaccine-shows-promise-in-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T22:50:35.000Z",
  "source": {
    "name": "Semafor",
    "slug": "semafor",
    "url": "https://www.semafor.com/article/08/19/2026/modernas-skin-cancer-vaccine-shows-promise-in-trial"
  },
  "original_language": "en",
  "account": null,
  "summary": "Moderna and Merck have announced the promising results of an experimental skin cancer vaccine, intismeran, in a recent trial. The vaccine, built on the same mRNA platform that enabled Moderna to rapidly develop COVID-19 vaccines, is genetically personalized to instruct the patient's immune system to target tumors and slow down the progression of melanoma. This type of \"neoantigen\" vaccine has been considered a promising approach in cancer treatment, but this late-stage trial marked the first time it was used to definitively prove its effectiveness. The announcement has caused Moderna's shares to surge by more than 175%, with the company's CEO claiming that the results demonstrate the potential of an entirely new class of medicine.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "The Indian Express",
        "title": "Moderna shares soar 150% after personalised cancer vaccine breakthrough",
        "url": "https://urgent.news/2026/08/19/moderna-shares-soar-150-after-personalised-cancer-vaccine-breakthrough",
        "published": "2026-08-19T17:22:25.000Z"
      },
      {
        "outlet": "Al Jazeera",
        "title": "Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread",
        "url": "https://urgent.news/2026/08/19/moderna-merck-unveil-mrna-based-cancer-vaccine-that-cuts-spread",
        "published": "2026-08-19T20:39:14.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}